Related
Which ads are winners? Your brain knows better than you do
Stuart Wolpert 30 Apr 2012
Home monitoring may help manage and reduce costs for heart failure
Rachel Champeau 3 Jan 2012
Killing brain cancer stem cells
Kim Irwin 21 Oct 2011
Adult stem cells found to suppress cancer while dormant
Researchers at UCLA's Eli and Edythe Broad Centre of Regenerative Medicine and Stem Cell Research have discovered a mechanism by which certain adult stem cells suppress their ability to initiate skin cancer during their dormant phase - an understanding that could be exploited for better cancer-prevention strategies.
Breast cancer tissue.
The study, which was led by UCLA postdoctoral fellow Andrew White and William Lowry, an associate professor of molecular, cell and developmental biology who holds the Maria Rowena Ross Term Chair in Cell Biology in the UCLA College of Letters and Science, was published online 15 December in the journal Nature Cell Biology.
Hair follicle stem cells, the tissue-specific adult stem cells that generate the hair follicles, are also the cells of origin for cutaneous squamous cell carcinoma, a common skin cancer. These stem cells cycle between periods of activation (during which they can grow) and quiescence (when they remain dormant).
Using mouse models, White and Lowry applied known cancer-causing genes to hair follicle stem cells and found that during their dormant phase, the cells could not be made to initiate skin cancer. Once they were in their active period, however, they began growing cancer.
A novel form of tumour suppression
"We found that this tumour suppression via adult stem cell quiescence was mediated by PTEN, a gene important in regulating the cell's response to signalling pathways," White said. "Therefore, stem cell quiescence is a novel form of tumour suppression in hair follicle stem cells, and PTEN must be present for the suppression to work."
Understanding cancer suppression through quiescence could better inform preventative strategies for certain patients, such as organ transplant recipients, who are particularly susceptible to squamous cell carcinoma, and for those taking the drug vemurafenib for melanoma, another type of skin cancer. The study also may reveal parallels between squamous cell carcinoma and other cancers in which stem cells have a quiescent phase.
Source: UCLA
